Artificial intelligence is changing how scientists study life by helping them interpret genetic information, predict the structures of proteins, discover potential medicines, and understand complex biological systems. Instead of relying entirely on experiments to investigate every possibility, researchers can use AI to analyze enormous biological datasets, identify patterns that would be difficult to detect manually, and generate predictions that guide further testing.
The impact is particularly significant in three connected areas: genes, which store biological instructions; proteins, which perform much of the work inside cells; and living systems, in which genes, proteins, cells, and environmental conditions interact. By connecting information across these levels, AI can help scientists move from describing biological components to understanding how they function together.
However, AI does not automatically explain how life works. Its predictions depend on the quality of the data, the assumptions built into its models, and the biological experiments used to evaluate its results. Understanding both its capabilities and its limitations is essential to understanding its role in modern biology.
How AI helps scientists study living things
Biology generates several kinds of data, including DNA sequences, protein measurements, microscopic images, chemical observations, and records of how organisms respond to different conditions. These data can be extremely large and difficult to interpret using traditional analytical methods alone.
AI refers to computational systems that learn patterns from data or use those patterns to make predictions, classify information, and support decisions. In biology, these systems can help identify meaningful relationships among millions of measurements, estimate properties that have not been directly observed, and prioritize which questions researchers should investigate experimentally.
Machine learning is one of the main approaches. A machine-learning model learns statistical relationships from examples rather than relying exclusively on a set of explicitly programmed rules. A model trained on known DNA sequences and their functions, for instance, may learn to recognize sequence patterns associated with particular biological processes.
Deep learning, a type of machine learning that uses multilayered artificial neural networks, is especially useful for complex data. These networks can learn relationships among DNA letters, amino acid sequences, molecular structures, and biological measurements. Some models also learn from large collections of unlabeled data, allowing them to capture general patterns before being adapted to a specific research question.
AI models generally produce predictions, classifications, or representations of data rather than direct proof of a biological mechanism. A prediction that two genes are associated, for example, does not establish that one gene controls the other. Scientists must distinguish between a pattern that a model detects and a causal relationship that experiments demonstrate.
How AI is transforming genetics
Genes are stretches of DNA that contain instructions for producing functional biological products, including proteins and certain types of RNA. The human genome contains billions of DNA letters, and the effects of genetic variation can depend on where a change occurs, how a gene is regulated, and which other biological processes are involved.
AI helps researchers analyze this information at a scale that would otherwise be difficult to manage.
Finding meaning in DNA sequences
DNA consists of four chemical bases, commonly represented by the letters A, C, G, and T. The order of these bases carries genetic information, but a sequence alone does not reveal everything about how a gene behaves.
Some DNA regions encode proteins. Others help regulate when, where, and how strongly genes are expressed. Many regulatory regions lie outside protein-coding genes, and their effects can depend on the cell type and biological conditions.
Machine-learning models can analyze DNA sequences to identify patterns associated with gene boundaries, regulatory elements, RNA processing, and other features. They can also help researchers predict how a genetic variant—a difference in DNA sequence—might affect a biological process.
Consider a single-letter change in a regulatory region. Such a change might alter the binding of a transcription factor, a protein that helps control gene activity. An AI model may predict that the variant weakens binding and reduces gene expression. That prediction gives researchers a testable hypothesis, but it does not establish that the change produces the predicted effect in an actual organism.
The distinction matters because DNA sequences contain many patterns that correlate with biological functions without necessarily causing them. A reliable interpretation may require experiments in relevant cells, measurements of gene activity, and evidence that other genetic or environmental factors do not explain the observed effect.
Understanding gene expression
Genes are not active at the same level in every cell. A liver cell and a neuron contain largely the same inherited DNA, yet they perform different functions because they use different sets of genes and regulate those genes differently.
Gene expression describes the process by which information in a gene is used to produce a functional product. For protein-coding genes, this generally involves making RNA from DNA and then translating messenger RNA into protein.
Researchers can measure gene expression using methods such as RNA sequencing, which determines the RNA molecules present in a sample. AI can help classify cell types, identify genes associated with particular conditions, and detect patterns that distinguish healthy tissue from diseased tissue.
Single-cell RNA sequencing makes this work more detailed by measuring gene expression in individual cells rather than averaging signals across an entire tissue. Because biological samples may contain many different cell types and states, computational models are useful for separating these signals and identifying populations that would otherwise be difficult to recognize.
For example, a tumor sample may contain cancer cells, immune cells, connective tissue cells, and other components. AI-assisted analysis can help distinguish these populations and identify differences in their activity. This may reveal which cell types are associated with disease progression or treatment response.
Yet gene-expression patterns require careful interpretation. A gene that becomes more active during a disease may contribute to the disease, respond to it, or reflect a change in the mixture of cells within the sample. Additional experiments are needed to determine which explanation is correct.
How AI predicts protein structures and functions
Proteins are molecules made from chains of amino acids. They act as enzymes, receptors, antibodies, structural components, transporters, and regulators of cellular activity. Their functions depend heavily on how their amino acid chains fold into three-dimensional structures and how those structures interact with other molecules.
Predicting protein structure from sequence has long been a central challenge in biology. Experimental methods can reveal detailed molecular structures, but obtaining such information can require substantial time, specialized equipment, and difficult preparation.
AI has greatly expanded scientists’ ability to predict protein structures from amino acid sequences.
From amino acid sequences to three-dimensional structures
A protein’s amino acid sequence constrains the structures it can adopt. Interactions among amino acids, the surrounding chemical environment, and interactions with other molecules influence how the protein folds and behaves.
Modern structure-prediction systems learn relationships between protein sequences, evolutionary patterns, and known molecular structures. Some use information from related proteins to infer which amino acid positions are likely to interact. Others employ deep-learning architectures that estimate spatial relationships among parts of a molecule and use those estimates to produce a structural model.
AlphaFold, developed by DeepMind, demonstrated how AI could predict many protein structures with remarkable accuracy. Related advances have broadened computational approaches to studying molecular interactions and complexes.
These predictions help researchers investigate proteins whose structures have not been experimentally determined. A predicted structure can suggest the location of an active site, reveal a possible binding pocket, or help explain how a mutation might alter a protein’s shape.
The consequences extend to many areas of biology. Scientists studying an enzyme may use a structural model to identify amino acids that could be important for catalysis. Researchers investigating an inherited disorder may examine whether a genetic change is likely to disrupt the structure of a protein essential for normal cell function.
Nevertheless, a predicted structure is not a complete description of a protein. Some proteins contain flexible regions or adopt several conformations. Their behavior can depend on binding partners, chemical modifications, cellular conditions, and the presence of membranes or other molecules. A static structural prediction may not capture these features adequately.
Experimental measurements remain important for confirming structural predictions and determining how proteins behave under biologically relevant conditions.
Predicting protein function and molecular interactions
Knowing a protein’s shape does not necessarily reveal its complete function. Two proteins may have similar structures but perform different tasks, while proteins with different structures can sometimes carry out related functions.
AI models can combine sequence information, structural features, evolutionary relationships, and experimental observations to predict possible protein functions. They can also help identify potential interactions between proteins and other molecules.
This capability is valuable because cells operate through networks of molecular interactions. Proteins rarely function in isolation. They bind to other proteins, recognize DNA or RNA, transport molecules, and participate in chemical reactions that influence many downstream processes.
AI can help prioritize likely interactions for laboratory testing. However, predicting that two molecules may bind is not the same as demonstrating that they interact in a living cell. A predicted interaction might be physically possible but biologically irrelevant under normal conditions. Researchers must determine whether the molecules encounter each other, bind with sufficient strength, and produce a meaningful effect.
How AI supports drug discovery
Developing a medicine requires identifying a biological target, finding or designing molecules that affect it, testing whether those molecules work as intended, and evaluating their safety. Each stage involves uncertainty, and many promising candidates fail during development.
AI can help researchers narrow the range of possibilities and make better use of experimental resources.
One important application is identifying potential drug targets. By analyzing genetic evidence, gene-expression data, protein networks, and disease-related measurements, models can help identify molecules that may contribute to a disease process.
Once researchers select a target, AI can assist with finding candidate compounds. Models can estimate how molecules might bind to a protein, predict certain chemical properties, or identify structures worth testing. Generative models can also propose new molecular structures that meet specified design goals, such as interacting with a target while avoiding certain undesirable properties.
These methods are useful because the number of possible drug-like molecules is enormous. Computational screening can prioritize a manageable subset for synthesis and laboratory evaluation.
AI may also help predict properties relevant to drug development, including solubility, stability, metabolism, and toxicity. Such predictions can help researchers identify potential problems earlier, although their accuracy varies by property and by the chemical compounds represented in the training data.
The distinction between a promising candidate and an effective medicine is crucial. A molecule may bind tightly to a protein yet fail to influence the disease in a useful way. It may be unable to reach the relevant tissue, break down too quickly, cause harmful effects, or behave differently in a whole organism than it does in a laboratory assay.
Drug development therefore remains an experimental process. AI helps researchers decide what to test; it does not eliminate the need for biochemical studies, cell experiments, animal studies where appropriate, clinical trials, or regulatory evaluation.
How AI helps scientists understand cells and biological systems
Living organisms are more than collections of genes and proteins. Their behavior emerges from interactions among molecules, cells, tissues, organs, and environmental conditions. These interactions can produce effects that are difficult to predict by studying each component separately.
Systems biology investigates these interconnected processes. AI is particularly useful in this field because many biological outcomes depend on multiple variables changing together.
Reconstructing biological networks
Scientists often represent biological relationships as networks. In a gene-regulatory network, for example, genes and regulatory molecules are connected according to how they influence gene activity. In a protein-interaction network, connections represent known or suspected molecular interactions.
AI can analyze these networks to identify important components, predict missing connections, and detect groups of molecules that may work together. A group of interacting proteins might participate in the same cellular process, while a regulatory network may reveal how cells coordinate responses to stress or changes in their environment.
Network analysis can also help explain why a disease affects several biological processes at once. A genetic alteration may influence one protein, which changes the activity of other proteins and ultimately disrupts a wider cellular pathway.
However, biological networks are often incomplete. Some interactions have been studied extensively, while others remain unknown. Connections may also vary across cell types, developmental stages, and environmental conditions. A model trained on an incomplete network can produce plausible but incorrect conclusions if those gaps are not considered.
Integrating different kinds of biological data
A major challenge in biology is that different measurement techniques capture different aspects of the same system. DNA sequencing reveals genetic information; RNA sequencing measures gene activity; protein measurements indicate which proteins are present and sometimes their abundance; and chemical analyses can reveal metabolites, the small molecules involved in cellular processes.
The integration of these data types is often called multi-omics. The term omics refers to large-scale studies of biological components, such as genes, RNA, proteins, or metabolites.
AI can help researchers combine these measurements to develop a more complete picture of biological states. For example, gene activity may suggest that a metabolic pathway is active, while measurements of proteins and metabolites can provide additional evidence about whether that pathway is functioning as expected.
This integrated approach can be particularly valuable in cancer research, immunology, and the study of complex diseases. Two patients with the same clinical diagnosis may have different underlying molecular changes, which can influence their disease progression and response to treatment.
Combining data across biological levels may help reveal those differences. But integration also introduces technical challenges: measurements may come from different instruments, use different scales, or contain missing values. Computational methods must distinguish genuine biological variation from differences caused by sample preparation, measurement technology, or data processing.
AI in ecology, evolution, and the study of whole organisms
AI’s role in biology extends beyond molecular research. Scientists also use computational models to study evolution, animal behavior, populations, and ecosystems.
In evolutionary biology, AI can help compare genetic sequences, identify patterns of relatedness, and investigate how proteins or other biological features have changed over time. By examining similarities and differences among sequences from different organisms, researchers can infer evolutionary relationships and identify changes that may be associated with particular functions.
AI can also help analyze large collections of ecological observations. Models trained on recordings, photographs, sensor measurements, or environmental data can assist with identifying species, tracking animal movements, detecting changes in habitat use, and monitoring population trends.
In microbial ecology, computational methods can help characterize the communities of bacteria, fungi, and other microorganisms found in environments such as soil, oceans, and the human body. Researchers can then investigate how these communities change with environmental conditions or influence larger biological processes.
These applications share an important feature: AI helps extract patterns from observations that are too numerous or complex to evaluate efficiently by hand. Yet detecting a pattern does not necessarily explain why it exists. For example, a model may find that a species is more common under certain environmental conditions without establishing whether temperature, food availability, habitat structure, or another factor is responsible.
Understanding ecosystems and evolutionary processes therefore requires biological knowledge, appropriate sampling, and careful testing of competing explanations.
How AI models learn from biological data
The usefulness of an AI system depends partly on how it is trained and what information it receives. Biological datasets are often more difficult to assemble and interpret than ordinary collections of text or images because experiments can be expensive, measurements can be noisy, and the underlying systems vary across organisms and conditions.
In supervised learning, researchers provide examples paired with known outcomes. A model might learn from DNA sequences labeled according to whether they contain a particular regulatory feature, or from chemical compounds with experimentally measured properties.
In self-supervised learning, a model learns patterns from data without requiring a human-provided label for every example. For instance, a protein model might learn statistical relationships among amino acid sequences by predicting masked or missing parts of a sequence. Those learned relationships can later support predictions about structure or function.
After training, a model must be evaluated on data that were not used to fit it. This helps researchers estimate how well it performs on unfamiliar examples. However, a model may still appear more accurate than it really is if the training and test data contain closely related sequences, repeated measurements, or other forms of overlap.
This issue is especially important in biology because related organisms, genes, and proteins can share substantial information. A model that performs well on familiar biological families may struggle with a genuinely new sequence or a different experimental setting.
Researchers therefore need evaluation methods that match the intended use. A model intended to predict the effects of genetic variants in humans, for example, should be tested on relevant variants and biological contexts rather than judged solely by its performance on a broad collection of unrelated examples.
What AI cannot yet tell scientists about biology
AI can be exceptionally good at finding statistical patterns, but biological understanding requires more than accurate pattern recognition.
One limitation is the difference between correlation and causation. If two genes are consistently active at the same time, a model may identify a strong association between them. That does not prove that either gene directly regulates the other. Both might respond to a third factor, or their apparent relationship might result from differences among the samples.
Causal questions often require interventions. Researchers may disable a gene, alter a regulatory sequence, inhibit a protein, or change an environmental condition and then observe what happens. These experiments help establish whether a particular factor contributes to an outcome.
Another limitation is that living systems are context-dependent. A genetic variant can have different effects in different tissues. A protein may behave differently depending on its binding partners. A treatment that works in cultured cells may fail in an organism because of metabolism, immune responses, tissue barriers, or interactions among organs.
AI models can also inherit biases from their training data. If certain populations, organisms, environments, or experimental conditions are poorly represented, predictions may be less reliable for those cases. This is a concern in human genetics and medicine, where uneven representation can lead to unequal predictive performance across populations.
Finally, biological systems can be difficult to measure completely. Missing data, uncertain labels, and differences between laboratory techniques can limit what a model learns. A confident prediction does not guarantee that the underlying evidence is strong.
For these reasons, the most useful AI systems are not necessarily those that produce the most impressive predictions. They are those whose limitations are understood, whose performance has been tested in relevant settings, and whose results can be examined through independent evidence.
How AI and laboratory experiments work together
AI is most powerful in biology when computation and experimentation inform each other. Computational models can search large datasets, suggest hypotheses, and identify promising experiments. Laboratory results can then confirm or challenge those predictions, generating new data that improve subsequent models.
Suppose researchers want to understand why a particular genetic variant is associated with a disease. An AI model might predict that the variant changes the binding of a regulatory protein. Scientists could test that prediction by measuring binding, examining gene expression in relevant cells, and determining whether altering the regulatory interaction changes the cellular outcome.
If the experiments support the prediction, researchers gain evidence for a mechanism. If the results disagree, they can revise the hypothesis, investigate missing factors, or improve the model. Either outcome can advance understanding.
This cycle is sometimes called a closed-loop approach when computational predictions directly guide the next experiments and the resulting measurements feed back into the analysis. In some laboratories, automated instruments can carry out selected experiments and return measurements for further computational analysis, allowing certain research steps to be repeated more efficiently.
Automation does not remove the need for scientific judgment. Researchers must still decide which questions matter, whether an experiment is well designed, whether the data are reliable, and whether the conclusions are justified.
The broader significance of AI in biology lies in this partnership. Genetic sequences, protein structures, molecular interactions, and living systems produce vast amounts of information, but information alone does not explain life. AI can help scientists identify patterns and focus their efforts; experiments and biological reasoning determine which explanations withstand scrutiny. Together, these methods are making it possible to investigate biological questions at scales and levels of detail that were previously much harder to reach.